TERN
Companies
NASDAQ
Terns Pharmaceuticals Inc.
Health Care
$4.00
-$1.54 (-27.80%)
Price Chart
Overview
About TERN
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.
Market Cap
$462.4M
Volume
4.7M
Avg. Volume
4.2M
P/E Ratio
-1.4496404
Dividend Yield
0.00%
Employees
55.0
Company Information
Latest News for TERN
Top 3 Health Care Stocks You'll Regret Missing In Q4
November 19, 2024
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
January 17, 2024
Down -39.83% in 4 Weeks, Here's Why Terns Pharmaceuticals (TERN) Looks Ripe for a Turnaround
April 7, 2025
Risk & Correlation Analysis
Market Correlation
0.49
Low Correlation
Volatility
High (0.75)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, TERN shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$462.4M
Volume4.7M
P/E Ratio-1.45
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 21, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025